# Immunai

**Source:** https://www.startuphub.ai/startups/immunai
**Profile type:** Startup

> Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

## About

Immunai decodes the human immune system at unprecedented scale and resolution to facilitate the development of next-generation immune-related therapeutics. Their platform supports drug discovery and development by identifying novel targets, evaluating preclinical candidates, and optimizing clinical trials. They partner with biopharmaceutical companies and research institutions to provide actionable recommendations for advancing therapies.

## Key facts

- **Slug:** immunai
- **Website:** http://immunai.com
- **Location:** New York, United States
- **Founded:** 2019-01-01 00:00:00
- **Employees:** 179
- **Operating status:** Active
- **Total funding:** $295M
- **Sectors / tags:** Healthcare, Immunology, Data, Analytics, Personalized Treatment, Drug Development, Computational Biology, Life Sciences, Therapeutics, Biotech, HealthTech, Drug Discovery, Genomics, AI-Driven Drug Discovery, Single-Cell Biology, Clinical Trials, Precision Medicine
- **Social:**
  - LinkedIn: https://www.linkedin.com/company/immunai/
  - Twitter: https://twitter.com/Immunaitech

## Frequently asked

### What does Immunai do?

Immunai decodes the human immune system at unprecedented scale and resolution to facilitate the development of next-generation immune-related therapeutics. Their platform supports drug discovery and development by identifying novel targets, evaluating preclinical candidates, and optimizing clinical trials. They partner with biopharmaceutical companies and research institutions to provide actionable recommendations for advancing therapies.

### What is Immunai's revenue?

StartupHub estimates Immunai's annual revenue at $35.5M (range $17.9M to $51.3M, 67% confidence), based on comparable companies in the sector.

### What is Immunai's valuation?

StartupHub estimates Immunai's effective valuation at $597.2M (range $418.1M to $776.4M, 27% confidence), based on comparable companies in the sector.

### How much funding has Immunai raised?

Immunai has raised a total of $295M in funding. The most recent round on record is Series B.

### Where is Immunai headquartered?

Immunai is headquartered in New York, United States.

### When was Immunai founded?

Immunai was founded in 2019.

### What industry does Immunai operate in?

Immunai operates in Healthcare, Immunology, Data, Analytics, Personalized Treatment, Drug Development.

### How many employees does Immunai have?

Immunai has approximately 179 people on record.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Immunai",
          "item": "https://www.startuphub.ai/startups/immunai"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/immunai#webpage",
      "url": "https://www.startuphub.ai/startups/immunai",
      "name": "Immunai - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of Immunai. Immunai is a startup founded in 2019, operating in Healthcare and Immunology. Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery. Headquartered in New York, United States. The company has approximately 179 employees.",
      "dateModified": "2026-07-01T09:30:43.137864+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/immunai#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/immunai#organization",
      "name": "Immunai",
      "url": "http://immunai.com",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/1c90bfc5-52c5-41ce-bce0-331eb309531c-square.webp",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/1c90bfc5-52c5-41ce-bce0-331eb309531c-square.webp",
      "description": "This is the official profile of Immunai. Immunai is a startup founded in 2019, operating in Healthcare and Immunology. Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery. Headquartered in New York, United States. The company has approximately 179 employees.",
      "sameAs": [
        "https://www.linkedin.com/company/immunai/",
        "https://twitter.com/Immunaitech",
        "https://www.startuphub.ai/startups/immunai"
      ],
      "foundingDate": "2019-01-01 00:00:00",
      "numberOfEmployees": {
        "@type": "QuantitativeValue",
        "value": 179
      },
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "New York",
        "addressCountry": "US"
      },
      "knowsAbout": [
        "Healthcare",
        "Immunology",
        "Data",
        "Analytics",
        "Personalized Treatment",
        "Drug Development",
        "Computational Biology",
        "Life Sciences",
        "Therapeutics",
        "Biotech",
        "HealthTech",
        "Drug Discovery",
        "Genomics",
        "AI-Driven Drug Discovery",
        "Single-Cell Biology",
        "Clinical Trials",
        "Precision Medicine"
      ]
    },
    {
      "@type": "Product",
      "@id": "https://www.startuphub.ai/startups/immunai#profile-assessment",
      "name": "Immunai - StartupHub.ai Profile Assessment",
      "url": "https://www.startuphub.ai/startups/immunai",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/1c90bfc5-52c5-41ce-bce0-331eb309531c-square.webp",
      "category": "Healthcare",
      "description": "This is the official profile of Immunai. Immunai is a startup founded in 2019, operating in Healthcare and Immunology. Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery. Headquartered in New York, United States. The company has approximately 179 employees. Agent Readiness score: 32/100. Full audit: https://www.startuphub.ai/startups/immunai/agent-readiness",
      "brand": {
        "@type": "Brand",
        "name": "Immunai"
      },
      "review": {
        "@type": "Review",
        "author": {
          "@type": "Organization",
          "name": "StartupHub.ai"
        },
        "datePublished": "2026-07-01",
        "name": "Immunai - Profile Score 79/100",
        "reviewBody": "This is the official profile of Immunai. Immunai is a startup founded in 2019, operating in Healthcare and Immunology. Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery. Headquartered in New York, United States. The company has approximately 179 employees. Agent Readiness score: 32/100. Full audit: https://www.startuphub.ai/startups/immunai/agent-readiness",
        "reviewRating": {
          "@type": "Rating",
          "ratingValue": 79,
          "bestRating": 100,
          "worstRating": 0
        }
      }
    }
  ]
}
```